For a primary care physician in Mexico City or São Paulo, the clinical day doesn't end when the last patient leaves the office. It continues, relentlessly, in the green bubble of a WhatsApp chat. Appointment requests, medication questions, lab results, and follow-up photos spill into a single, chaotic stream alongside messages from family and friends. The burden is real, unremunerated, and a primary driver of burnout. Leona Health, a Mexico City-based startup, isn't trying to replace that channel. Instead, it's building an AI layer directly on top of it, aiming to turn a source of administrative chaos into a manageable clinical workflow.
Founded in 2023, Leona has secured $14 million in seed funding led by Andreessen Horowitz to pursue this wedge [VentureCapital.com, 2025 (estimated)]. The product is an assistant that integrates with a doctor's existing WhatsApp number. It ingests incoming messages, prioritizes them by urgency, drafts suggested responses for review, and helps organize patient lists and tasks [MEXC News]. Early users report saving two to three hours daily previously spent managing this communication [mexc.com]. Leona's bet is that by giving clinicians back those hours, it can improve both practitioner well-being and the consistency of care.
The Wedge Is the Channel
Leona's strategy is defined by a clear geographic and behavioral insight. In many parts of Latin America, WhatsApp is the default, trusted medium for doctor-patient communication. Leona meets the user where they already are. Its AI co-pilot operates within the WhatsApp environment doctors and patients already use, requiring no change in behavior from either party [MEXC News]. The company claims it is now active with doctors across 14 countries and more than 22 medical specialties [tucson.com, 2026].
A Team Built for Scale and Context
| Role | Name | Key Background |
|---|---|---|
| Founder & CEO | Caroline Merin | Former COO of Rappi, Uber Eats alum [MEXC News] |
| Chief Technology Officer | Tom Chokel | Former Google AdWords engineer, co-founder of Modern Fertility [TechCrunch, 2013] [Crunchbase] |
| Head of Operations | Arela Solis | Former program leader for Latin America at Elevation W [theorg.com, 2026] |
Merin's experience scaling Rappi provides a foundational understanding of building and operating complex, high-volume platforms in the region. Chokel's background in both large-scale systems at Google and healthtech at Modern Fertility bridges the technical and clinical domains. Solis adds deep roots in Latin American venture and social impact.
The Investor Conviction
The $14 million seed round is notable for its composition. Andreessen Horowitz (a16z) led the round, with participation from General Catalyst and Accel [theaiinsider.tech, 2025]. The investor list also includes individual checks from Kate Ryder (founder of Maven Clinic), David Vélez (founder of Nubank), and Simón Borrero (co-founder of Rappi) [MEXC News]. This syndicate signals strong belief in both the team and the specific market wedge.
Navigating the Inherent Risks
- Clinical accuracy and liability. An AI drafting medical responses operates in a high-stakes domain. The company has not publicly detailed its model's training data, guardrails, or any regulatory clearances.
- Monetization and expansion. The initial focus on individual and small-group practices is a smart wedge. The long-term play likely involves moving upstream to larger clinics and health systems, which have more complex workflows and procurement cycles.
- Competitive response. Large telehealth platforms, EHR vendors, and even Meta itself could introduce similar features natively into WhatsApp Business, potentially eroding Leona's unique value proposition.
The Road Ahead
The immediate roadmap appears focused on scaling its existing wedge. The company is hiring for a Head of Growth, indicating a push to systematize its sales and customer success playbooks [Built In NYC]. The seed funding provides a substantial runway to prove unit economics and deepen its product moat before a likely Series A. Key milestones to watch will be published outcomes data, a move into larger enterprise contracts, and any announcements regarding partnerships with regional health providers or payers.